Significant neutralizing activity of human immunoglobulin preparations against pandemic 2009 H1N1
نویسندگان
چکیده
Ballen, K.K., Wilson, M., Wuu, J., Ceredona, A.M., Hsieh, C., Stewart, F.M., Popovsky, M.A. & Quesenberry, P.J. (2001) Bigger is better: maternal and neonatal predictors of hematopoietic potential of umbilical cord blood units. Bone Marrow Transplantation, 27, 7–14. Donaldson, C., Armitage, W.J., Laundy, V., Barron, C., Buchannan, R., Webster, J., Bradley, B. & Hows, J. (1999) Impact of obstetric factors on cord blood donation for transplantation. British Journal of Haematology, 106, 128–132. Ellis, J., Regan, F., Cockburn, H. & Navarette, C. (2007) Does ethnicity affect cell dose in cord blood donation? Transfusion Medicine, 17(Suppl 1), 50. Gluckman, E., Rocha, V., Arcese, W., Michel, G., Sanz, G., Chan, K.W., Takahashi, T.A., Ortega, J., Filipovich, A., Locatelli, F., Asano, S., Fagioli, F., Vowels, M., Sirvent, A., Laporte, J.P., Tiedemann, K., Amadori, S., Abecassis, M., Bordigoni, P., Diez, B., Shaw, P.J., Vora, A., Caniglia, M., Garnier, F., Ionescu, I., Garcia, J., Koegler, G., Rebulla, P. & Chevret, S.; Eurocord Group. (2004) Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice. Experimental Hematology, 32, 397–407. Jones, J., Stevens, C.E., Rubenstein, P., Robertazzi, R.R., Kerr, A. & Cabbad, F. (2003) Obstetric predictors of placental/umbilical cord blood volume for transplantation. American Journal of Obstetrics and Gynecology, 188, 503–509. Klein, H.G. & Anstee, D.J. (2005) Mollison’s Blood Transfusion in Clinical Medicine, 11th edn. Blackwell Publishing, London. Shlebak, A., Roberts, I.A.G., Stevens, T.A., Szydlo, R.M., Goldman, J.M. & Gordon, M.Y. (1998) The impact of antenatal and perinatal variables on cord blood stem/progenitor cell yield available for transplantation. British Journal of Haematology, 103, 1167–1171. Wagner, J.E., Barker, J.N., DeFor, T.E., Baker, K.S., Blazar, B.R., Eide, C., Goldman, A., Kersey, J., Krivit, W., MacMillan, M.L., Orchard, P.J., Peters, C., Weisdorf, D.J., Ramsay, N.K. & Davies, S.M. (2002) Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and non-malignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood, 100, 1611–1618.
منابع مشابه
Pre-Existing Immunity with High Neutralizing Activity to 2009 Pandemic H1N1 Influenza Virus in Shanghai Population
Pre-existing immunity is an important factor countering the pandemic potential of an emerging influenza virus strain. Thus, studying of pre-existing immunity to the 2009 pandemic H1N1 virus (2009 H1N1) will advance our understanding of the pathogenesis and epidemiology of this emerging pathogen. In the present study, sera were collected from 486 individuals in a hospital in Shanghai, China, bef...
متن کاملFully human broadly neutralizing monoclonal antibodies against influenza A viruses generated from the memory B cells of a 2009 pandemic H1N1 influenza vaccine recipient.
Whether the 2009 pandemic H1N1 influenza vaccine can induce heterosubtypic cross-protective anti-hemagglutinin (HA) neutralizing antibodies is an important issue. We obtained a panel of fully human monoclonal antibodies from the memory B cells of a 2009 pandemic H1N1 influenza vaccine recipient. Most of the monoclonal antibodies targeted the HA protein but not the HA1 fragment. Among the analyz...
متن کاملDetection of Extensive Cross-Neutralization between Pandemic and Seasonal A/H1N1 Influenza Viruses Using a Pseudotype Neutralization Assay
BACKGROUND Cross-immunity between seasonal and pandemic A/H1N1 influenza viruses remains uncertain. In particular, the extent that previous infection or vaccination by seasonal A/H1N1 viruses can elicit protective immunity against pandemic A/H1N1 is unclear. METHODOLOGY/PRINCIPAL FINDINGS Neutralizing titers against seasonal A/H1N1 (A/Brisbane/59/2007) and against pandemic A/H1N1 (A/Californi...
متن کاملPreexisting Immunity to Pandemic (H1N1) 2009
To the Editor: The infl uenza A pandemic (H1N1) 2009 virus contains a combination of 8 gene segments (1–3) antigenically similar to North American infl uenza A virus (H1N1) but different from seasonal human infl uenza A viruses (H1N1) (3). Despite the initial high number of deaths among patients in Mexico and among patients with specifi c preex-isting conditions, pandemic (H1N1) 2009 virus in g...
متن کاملMolecular cloning of the first human monoclonal antibodies neutralizing with high potency swine-origin influenza A pandemic virus (S-OIV).
The pandemic caused by the new H1N1 swine-origin influenza virus (S-OIV) strain is a worldwide health emergency and alternative therapeutic and prophylactic options are greatly needed. Two human monoclonal antibody Fab fragments (HMab) neutralizing the novel H1N1 influenza strain at very low concentrations were cloned from a patient who had a broad-range anti-H1N1 serum neutralizing activity. T...
متن کاملThe 2009 H1N1 Pandemic Influenza in Korea.
In late March of 2009, an outbreak of influenza in Mexico, was eventually identified as H1N1 influenza A. In June 2009, the World Health Organization raised a pandemic alert to the highest level. More than 214 countries have reported confirmed cases of pandemic H1N1 influenza A. In Korea, the first case of pandemic influenza A/H1N1 infection was reported on May 2, 2009. Between May 2009 and Aug...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره 148 شماره
صفحات -
تاریخ انتشار 2010